PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Nano Regulatory News (ONT)

Share Price Information for Oxford Nano (ONT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 108.20
Bid: 108.20
Ask: 108.60
Change: -3.30 (-2.96%)
Spread: 0.40 (0.37%)
Open: 112.80
High: 112.80
Low: 107.00
Prev. Close: 111.50
ONT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Share Incentive Plan - Director/PDMR Shareholding

13 Sep 2022 17:00

RNS Number : 3225Z
Oxford Nanopore Technologies plc
13 September 2022
 

13 September 2022

Oxford Nanopore Technologies plc (the "Company")

Share Incentive Plan ("SIP") PDMR Notification

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

The Company has been notified by Solium Trustee (UK) Limited, the trustee of the SIP (the "SIP Trustee") that on 13 September 2022, it made an award of Partnership Shares (as defined in the SIP) of 53 ordinary shares of £0.0001 each ("Ordinary Shares") on behalf of Tim Cowper, a director of the Company and a Person Discharging Managerial Responsibilities ("PDMR") and 53 Ordinary Shares on behalf of Clive Brown, a director of the Company and a PDMR. The Ordinary Shares were purchased using each participating employee's gross salary at a price of £2.88 per Ordinary Share.

Under the SIP, the SIP Trustee will award each participating employee one Matching Share (as defined in the SIP) for each Ordinary Share purchased by the employee under the SIP. On 13 September 2022, the Company issued 53 Ordinary Shares to the SIP Trustee to hold on behalf of Tim Cowper to satisfy the Matching Shares awarded under the SIP to him on that date, and 53 Ordinary Shares to the SIP Trustee to hold on behalf of Clive Brown to satisfy the Matching Shares awarded under the SIP to him on that date.

Further details of the transactions referred to above by the SIP Trustee are set out below:

Name of PDMR

Number of Partnership Shares

Number of Matching Shares

Tim Cowper (Director)

53

53

Clive Brown (Director)

53

53

 

This announcement is made pursuant to the Company's obligations under Article 19(3) of the UK Market Abuse Regulation.

Tim Cowper - purchase of shares under the SIP

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Timothy Cowper

2

Reason for the notification

a)

Position/status

Chief Financial Officer

b)

Initial/Amendment notification

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Oxford Nanopore Technologies plc

b)

LEI

213800IRWQ2Q6M2CDW55

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

 Ordinary shares of £0.0001 each

 

 

GB00BP6S8Z30

b)

Nature of the transaction

Purchase of Ordinary Shares under the SIP, held through the SIP Trustee.

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

£2.88

53

d)

Aggregated information

- Aggregated volume

- Aggregated price

 

53 shares

£152.64

 

e)

Date of the transaction

13 September 2022

f)

Place of the transaction

London Stock Exchange (XLON)

 

 

 

 

Tim Cowper - issue of new shares under the SIP

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Timothy Cowper

2

Reason for the notification

a)

Position/status

Chief Financial Officer

b)

Initial/Amendment notification

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Oxford Nanopore Technologies plc

b)

LEI

213800IRWQ2Q6M2CDW55

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

 Ordinary shares of £0.0001 each

 

 

GB00BP6S8Z30

b)

Nature of the transaction

Grant of Matching Shares through an issue of Ordinary Shares under the SIP, held through the SIP Trustee

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

Nil

53

d)

Aggregated information

- Aggregated volume

- Aggregated price

 

53 shares

Nil

e)

Date of the transaction

13 September 2022

f)

Place of the transaction

London Stock Exchange (XLON)

 

 

Clive Brown - purchase of shares under the SIP

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Clive Gavin Brown

2

Reason for the notification

a)

Position/status

Chief Technology Officer

b)

Initial/Amendment notification

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Oxford Nanopore Technologies plc

b)

LEI

213800IRWQ2Q6M2CDW55

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

 Ordinary shares of £0.0001 each

 

 

GB00BP6S8Z30

b)

Nature of the transaction

Purchase of Ordinary Shares under the SIP, held through the SIP Trustee.

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£2.88

53

d)

Aggregated information

- Aggregated volume

- Aggregated price

 

53 shares

£152.64

e)

Date of the transaction

13 September 2022

f)

Place of the transaction

London Stock Exchange (XLON)

 

 

Clive Brown - issue of new shares under the SIP

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Clive Gavin Brown

2

Reason for the notification

a)

Position/status

Chief Technology Officer

b)

Initial/Amendment notification

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Oxford Nanopore Technologies plc

b)

LEI

213800IRWQ2Q6M2CDW55

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

 Ordinary shares of £0.0001 each

 

 

GB00BP6S8Z30

b)

Nature of the transaction

Grant of Matching Shares through an issue of Ordinary Shares under the SIP, held through the SIP Trustee

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

Nil

53

d)

Aggregated information

- Aggregated volume

- Aggregated price

 

53 shares

Nil

e)

Date of the transaction

13 September 2022

f)

Place of the transaction

London Stock Exchange (XLON)

 

Enquiries:

Investors

ir@nanoporetech.com 

Media 

media@nanoporetech.com

oxfordnanoporetechnologies@tulchangroup.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEASNDFENAEFA
Date   Source Headline
1st Sep 20233:00 pmRNSIssue of Equity and Total Voting Rights
25th Aug 202312:00 pmRNSNotice of Results and Capital Markets Day
11th Aug 20235:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
1st Aug 20235:30 pmRNSIssue of Equity and Total Voting Rights
17th Jul 20237:00 amRNSHalf Year Trading Update
13th Jul 20233:30 pmRNSKate Priestman appointed as Non-Executive Director
11th Jul 20235:30 pmRNSShare Incentive Plan - Director/PDMR Shareholding
3rd Jul 20233:30 pmRNSIssue of Equity and Total Voting Rights
13th Jun 20234:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
12th Jun 20233:30 pmRNSResult of AGM
12th Jun 20237:00 amRNSNational German rare disease study
9th Jun 20237:00 amRNSChange of Broker
1st Jun 20233:00 pmRNSIssue of Equity and Total Voting Rights
19th May 20237:00 amRNSLondon Calling Technology Update
12th May 20231:30 pmRNSHolding(s) in Company
12th May 20238:35 amRNSNext step of PathoQuest strategic collaboration
11th May 20234:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
4th May 20234:30 pmRNSDirector/PDMR Notification
2nd May 20233:00 pmRNSIssue of Equity and Total Voting Rights
26th Apr 20237:00 amRNSPublication of Annual Report and Notice of AGM
17th Apr 20237:00 amRNSNew infectious disease partnership with bioMerieux
13th Apr 20236:00 pmRNSDirector/PDMR Shareholding
12th Apr 20234:00 pmRNSLTIP and DBP; Director/PDMR Notification
12th Apr 20234:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
11th Apr 20237:00 amRNSNIH Alzheimers study shows scaled, accurate data
6th Apr 20234:00 pmRNSBlock listing Interim Review
3rd Apr 20233:30 pmRNSIssue of Equity and Total Voting Rights
31st Mar 20237:00 amRNSNIHR, Oxford Nanopore announce new health study
21st Mar 20237:00 amRNSFinal results for the year ended 31 December 2022
13th Mar 20234:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
9th Mar 20237:00 amRNSNotice of Results
1st Mar 20233:30 pmRNSIssue of Equity and Total Voting Rights
27th Feb 20236:00 pmRNSChanges to Director Roles and Responsibilities
13th Feb 20235:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
1st Feb 20234:30 pmRNSTotal Voting Rights and Issue of Equity
17th Jan 20237:00 amRNSTrading update
13th Jan 20233:30 pmRNSDirector/PDMR Shareholding (ESPP)
11th Jan 20234:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
4th Jan 20235:30 pmRNSDirector/PDMR Shareholding (ESPP)
3rd Jan 20235:00 pmRNSIssue of equity and Total Voting Rights
28th Dec 20223:00 pmRNSHolding(s) in Company
23rd Dec 202212:00 pmRNSHolding(s) in Company
13th Dec 20224:50 pmRNSShare Incentive Plan - Director/PDMR Shareholding
1st Dec 20223:00 pmRNSIssue of Equity and Total Voting Rights
11th Nov 20224:30 pmRNSShare Incentive Plan - Director/PDMR Shareholding
11th Nov 20224:30 pmRNSDirector/PDMR Shareholding
1st Nov 20225:00 pmRNSIssue of Equity and Total Voting Rights
11th Oct 20224:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
10th Oct 202212:00 pmRNSDirector/PDMR Shareholding
6th Oct 20225:30 pmRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.